Gossamer Bio, Inc. (NASDAQ:GOSS) earns a spot on our list of the best penny stocks set to explode. As of April 8, 2026, ...
Gossamer Bio is picking up the pieces after failing to bring its only late-stage drug to market. The local biotech plans to lay off 65 San Diegans, almost half of its total workforce. While the ...
As of April 8, 2026, sentiment around Gossamer Bio, Inc. (NASDAQ:GOSS) remains cautious, with 56% of covering analysts ...
Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 1, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise ...
Gossamer Bio, Inc. (NASDAQ:GOSS) is one of the 8 Most Oversold Penny Stocks to Buy Right Now. On March 23, 2026, Cantor ...
The Gross Law Firm issues the following notice to shareholders of Gossamer Bio, Inc. (NASDAQ: GOSS). Shareholders who purchased shares of GOSS during the class period listed are encouraged to contact ...
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GOSSAMER BIO, INC. (GOSS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
- Following PROSERA Phase 3 topline results, the Company is focused on evaluating the totality of the dataset, engaging with the FDA, and assessing strategic options and capital allocation - - ...
Gossamer Bio, Inc (NASDAQ:GOSS) is one of the 10 Best High-Risk Penny Stocks to Buy Right Now. Gossamer Bio, Inc (NASDAQ:GOSS ...
- Gossamer to Present Preclinical Evidence of Synergistic Treatment Effect from Combination Seralutinib & Sotatercept in Models of PAH - “Gossamer is committed to generating and presenting data that ...
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary ...
View source version on businesswire.com: https://www.businesswire.com/news/home/20250313732742/en/ For Investors and Media: Bryan Giraudo, Chief Financial Officer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results